Bioavailability of vitamin D2 and D3 in healthy volunteers, a randomized placebo-controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 11, 2013, Pages 4339-4345

  Lehmann, Ulrike ^a   Hirche, Frank ^a   Stangl, Gabriele I ^a   Hinz, Katja ^b   Westphal, Sabine ^b   Dierkes, Jutta ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GERMANY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARALLEL DESIGN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; VOLUNTEER; WINTER;

25-HYDROXYVITAMIN D 2; ADULT; AGED; BIOLOGICAL AVAILABILITY; CALCIFEDIOL; CHOLECALCIFEROL; ERGOCALCIFEROLS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; PLACEBOS; VITAMINS; YOUNG ADULT;

EID: 84887465084     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4287     Document Type: Article

References (32)

1. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitaminDstatus: a systematic review and meta-analysis.AmJ Clin Nutr. 2012;95: 1357-1364.
2. Pramyothin P, Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol. 2012;28: 139-150.
3. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol. 1981;77: 51-58.
4. Romagnoli E, Mascia ML, Cipriani C, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab. 2008;93: 3015-3020.
5. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab. 2011;96:E447-E452.
6. TrangHM,Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68: 854-858.
7. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25- hydroxyvitamin D. J Clin Endocrinol Metab. 2008;93: 677-681.
8. Biancuzzo RM, Young A, Bibuld D, et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr. 2010;91: 1621-1626.
9. Hintzpeter B, Scheidt-Nave C, Müller MJ, Schenk L, Mensink GB. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr. 2008;138: 1482-1490.
10. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int. 1998;8(suppl 2): S7-S12.
11. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20: 713-719.
12. Shivane VK, Sarathi V, Bandgar T, Menon P, Shah NS. High prevalence of hypovitaminosis D in young healthy adults from the western part of India. Postgrad Med J. 2011;87(1030): 514-518.
13. Hyppönen E, Turner S, Cumberland P, Power C, Gibb I. Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. J Clin Endocrinol Metab. 2007;92: 4615-4622.
14. Lamberg-Allardt C, Ala-Houhala M, Ahola M, Parviainen MT, Räsänen L, Viakorpi J. VitaminDstatus of children and adolescents in Finland. Ann Nutr Metab. 1986;30: 267-272.
15. Nair R, Maseeh A. Vitamin D: The "sunshine" vitamin. J Pharmacol Pharmacother. 2012;3: 118-126.
16. Brot C, Vestergaard P, Kolthoff N, Gram J, Hermann AP, Sorensen OH. VitaminDstatus and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr. 2001;86(suppl 1):S97- S103.
17. Davies JH, Shaw NJ. Preventable but no strategy: vitamin D deficiency in the UK. Arch Dis Child. 2011;96: 614-615.
18. Harinarayan CV, Joshi SR. Vitamin D status in India - its implica-tions and remedial measures. J Assoc Physicians India. 2009;57: 40-48.
19. Gillie O. Sunlight robbery: a critique of public health policy on vitamin D in the UK. Mol Nutr Food Res. 2010;54: 1148-1163.
20. Tjellesen L, Hummer L, Christiansen C, Rødbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner. 1986;1: 407-413.
21. Binkley N, Gemar D, Engelke J, et al. Evaluation of ergocalciferol or cholecalciferol dosing 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab. 2011;96: 981-988.
22. Glendenning P,ChewGT,SeymourHM,et al. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Bone. 2009;45: 870-875.
23. Pepe J, Romagnoli E, Nofroni I, et al. Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int. 2005;16: 805-812.
24. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19: 73-78.
25. Hartwell D, Tjellesen L, Christiansen C, Rodbro P. Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy. Acta Neurol Scand. 1989;79: 487-492.
26. Armas LA, HollisBW,Heaney RP. VitaminD2is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89: 5387-5391.
27. Holmberg I, Berlin T, Ewerth S, Björkhem I. 25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3. Scand J Clin Lab Invest. 1986;46: 785-790.
28. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem. 1984;21: 81-86.
29. Bischoff-Ferrari HA, Willet WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169: 551-561.
30. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willet WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21: 1121-1132.
31. Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and cholecalciferol in CKD. Am J Kidney Dis. 2012;60: 139-156.
32. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D deficiency. Scand J Rheumatol. 2009;38: 149-153.